SCRI

Drug discovery services market to reach $16.6B in 2015

Monday, December 10, 2012 10:09 AM

A new report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015. That revenue forecast and others appear in “DrugDiscovery Outsourcing: World Market 2013-2023,” published in November 2012.

More... »

Epic Sciences completes $13M Series B financing to advance cancer diagnostics

Wednesday, November 14, 2012 12:01 PM

Epic Sciences, a La Jolla, Calif.-based private biotech company that develops breakthrough cancer diagnostics, completed a $13 million Series B equity financing. This financing includes new investors Domain Associates, Roche Venture Fund and Pfizer Venture Investments, in addition to undisclosed individual investors.

More... »

AmerisourceBergen signs 3 year supply agreement with Express Scripts

Thursday, August 2, 2012 09:56 AM

AmerisourceBergen, a global pharmaceutical services company based in Valley Forge, Penn., has signed a three year agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts on an annual basis, effective October 1, 2012.

More... »

Proteostasis, Scripps Research expand collaboration on cystic fibrosis

Friday, July 27, 2012 12:04 PM

Proteostasis Therapeutics, a therapeutics developer focusing on regulating protein homeostasis for neurodegenerative and orphan diseases, has expanded its collaboration with The Scripps Research Institute (TSRI) to encompass an additional funded research project focused on biology and the testing of small molecule modulators of protein folding and trafficking for the treatment of cystic fibrosis (CF).

More... »

Allscripts, Quintiles to develop software solutions for clinical and post-approval research

Thursday, July 12, 2012 12:37 PM

Quintiles, a fully integrated biopharmaceutical services company, and Allscripts, a software company, have entered a strategic partnership to jointly develop software solutions to enable improvements to the drug development process and demonstrate the value of biopharma products in the real world.

More... »

Scripps Research inks 5-year research collaboration with BMS

Friday, June 15, 2012 03:37 PM

The Scripps Research Institute, an independent, not-for-profit organization focused on research in the biomedical sciences, has entered into a five-year collaboration with Bristol-Myers Squibb (BMS) focusing on applying novel chemistry to drug discovery and synthesis.

More... »

Repligen enrolls first patient in phase I trial of Friedreich’s Ataxia

Monday, March 19, 2012 03:20 PM

Waltham, Mass.-based Repligen has enrolled the first patient in a phase I clinical trial of RG2833 in adult patients with Friedreich’s Ataxia (FA)—a debilitating, life-shortening, degenerative neuro-muscular disorder that currently has no treatment.

More... »

FDA approves first-ever med for Cushing’s syndrome

Friday, February 24, 2012 11:14 AM

The FDA has approved Korlym (mifepristone) 300mg tablets as a once-daily oral medicine to control hyperglycemia secondary to hypercorisolism in adults with endogenous Cushing’s syndrome, according to Corcept Therapeutics.

More... »

Medco shareholders approve merger with Express Scripts

Thursday, December 22, 2011 12:48 PM

More... »

Scrip names PPD best CRO

Friday, November 4, 2011 11:43 AM

More... »